[Will drug therapy for diabetes be restricted by evidence-based guidelines or structured management programs (DMPs)?]

Area of Science:

• Evidence-based medicine
• Clinical practice guidelines
• Diabetes management

Background:

• Misinterpretation of evidence-based medicine (EBM) can lead to an overreliance on randomized clinical trials (RCTs) for all treatment decisions.
• Sackett's definition of EBM emphasizes integrating clinical expertise with external research evidence.
• Disease management programs (DMPs) offer recommendations but must prioritize individual patient treatment goals.

Purpose of the Study:

• To clarify the appropriate interpretation of evidence-based medicine and clinical guidelines.
• To highlight the importance of integrating clinical expertise with external evidence in patient care.
• To discuss the role and flexibility of DMPs in diabetes management.

Main Methods:

• Literature review and conceptual analysis of evidence-based medicine principles.
• Interpretation of Sackett's definition of evidence-based medicine.
• Discussion of guideline adherence and deviations in the context of DMPs.

Main Results:

• Evidence-based medicine necessitates combining clinical experience with systematic research findings.
• Guidelines and DMPs should be interpreted flexibly, allowing for expert clinical judgment.
• Individualized treatment goals are paramount in diabetes management, justifying deviations from standard recommendations.

Conclusions:

• Effective EBM practice requires a synthesis of personal expertise and external evidence.
• Clinical guidelines and DMPs serve as a framework, not rigid rules, in patient care.
• Individualized patient needs and clinical judgment are essential for optimal diabetes management.